The HOT study: Efficacy and tolerability on the 36th month;Etude HOT: Efficacite et tolerance a 36 mois

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue 8, 1998, Pages 1043-1048

  Herpin, D ^a   Mallion, J M ^b   Benkritly, A ^c   Baguet, J P ^b   Tremel, F ^b  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Laboratoires Astra France   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; FELODIPINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0032132554     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hansson L, Zanchetti A for the HOT Study Group. The hypertension optimal treatment (HOT study. Patients characteristics : randomization, risk profiles and early blood pressure results. Blood Pressure 1994 ; 3 : 322-7.
2. Hansson L, Zanchetti A for the HOT Study Group. The hypertension optimal treatment (HOT) study : 12-month data on blood pressure and tolerability with special reference to age and gender. Blood Pressure 1995 ; 4 : 313-9.
3. Mallion JM, Pehrsson NG, Raveau-Landon C, Boutelant S, Ménard J. Tolérance clinique à court terme et long terme du traitement antihypertenseur au cours de l'étude HOT. Arch Mal Cœur 1996 ; 89 : 1093-6.
4. Herpin D, Ḿallion JM, Dahan R et al. Étude HOT : qualité du contrôle tensionnel après 2 ans de suivi des patients. Arch Mal Cœur 1997 ; 90 : 1175-9.
5. Mallion JM, Dahan R, Boutelant S, Benkritly A, Baguet JP, Noirclerc M. Tolérance clinique à long terme du traitement antihypertenseur au cours de l'étude HOT. Arch Mal Cœur 1997 ; 90 : 1165-8.
6. Hansson L for the HOT Study Group. The hypertension optimal treatment study. Blood Pressure 1993 ; 2 : 62-8.